Illumina

Youtube Subscribe

Open: 139.0 Close: 136.9 Change: -2.1

Stop reading the whole internet to decide if you want to invest in Illumina.

The game is changing. There is a new strategy to evaluate Illumina fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Illumina are: Illumina, Grail, Icahn, test, Carl, appeal, divest, and the …

Concept Map

Semantic Network

Stock Summary

Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. The company offers sequencing and array-based instruments and consumables, which include reagents, flow.

Today's Summary

Illumina hopes to finalize divestiture terms by the end of the second quarter of 2024. Activist investor Carl Icahn waged a proxy battle with Illumina over the failed acquisition of Grail.

Today's News

Illumina has elected not to pursue further appeals of the Fifth Circuit Court of Appeals decision. Illumina hopes to finalize divestiture terms by the end of the second quarter of 2024. Illumina has been appealing an FTC opinion and Order to divest itself of cancer test maker GRAIL. The order contended that an Illumina merger would lessen innovation in the U.S. market for multi-cancer early detection (MCED) tests. Activist investor Carl Icahn also blasted the decision. Carl Icahn to initiate proxy battle with Illumina — again. This comes just months after shareholders elected one of his candidates amid criticisms of Illumina acquisition of Grail. Illumina announced Sunday that it is divesting Grail, the early cancer-detection company it acquired for roughly $7 billion, after its legal battle with U.S. regulators. The FTC challenged Illuminas acquisition on antitrust grounds in March 2021. Illumina supplies DNA-sequencing services vital to these tests and any similar ones that could be offered by Grail competitors. Since purchasing Grail, Illuminas stock price has dropped by more than one-third this year. Activist investor Carl Icahn waged a proxy battle with Illumina over the failed acquisition of Grail. Analyst Price Forecast Suggests 1.99% Upside as of November 27, 2023, the average one-year price target for Illumina is 134.13. The projected annual revenue is 5,111MM, an increase of 14.47% projected annual non-GAAP EPS is 3.12. Illumina has been named to the Dow Jones Sustainability North America and World Indices for the fifth consecutive year. Illumina stock has received a consensus rating of buy. The 59 analysts offering price forecasts for Illumina have a median target of 247.34, with a high estimate of 460.00 and a low estimate of 100.00. The high in the last 52 weeks of Illumina was 238.40. Illumina stock (nasdaq:ilmn), quotes and news summary - benzinga.com. The Vanguard Group, Inc. Illumina Management Name Job Mickie Henshall. Illuminas DRAGEN Germline Pipeline provides end-to-end NGS analysis, including advanced error model calibration for increased accuracy. DRAGEN on BaseSpace Sequence Hub (BSSH) provides push button analysis capability in an intuitive, easy to use interface with compliance, and storage features of Base space Sequence Hub and Amazon Web Services. Carl Icahn issues open letter to Illumina stockholders of Illumina, Inc. Icahn: The fox should not guard the henhouse The biotech company Illumina said on Sunday that it would divest Grail , the cancer test maker it acquired for $7.1 billion in 2021. An appeals court sided with the F.T.C.s argument that the deal could harm.

Stock Profile

"Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; and whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. Further, it provides whole-genome sequencing, genotyping, NIPT, and product support services; and Galleri, a multi-cancer early detection test. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Further, it markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California."

Keywords

How much time have you spent trying to decide whether investing in Illumina? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Illumina are: Illumina, Grail, Icahn, test, Carl, appeal, divest, and the most common words in the summary are: illumina, product, sequence, learn, news, analysis, new, . One of the sentences in the summary was: Activist investor Carl Icahn waged a proxy battle with Illumina over the failed acquisition of Grail.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #illumina #product #sequence #learn #news #analysis #new.

Read more →

Youtube Subscribe

---